Literature DB >> 22363091

Sample size formulae for two-stage randomized trials with survival outcomes.

Zhiguo Li1, Susan A Murphy.   

Abstract

Two-stage randomized trials are growing in importance in developing adaptive treatment strategies, i.e. treatment policies or dynamic treatment regimes. Usually, the first stage involves randomization to one of the several initial treatments. The second stage of treatment begins when an early nonresponse criterion or response criterion is met. In the second-stage, nonresponding subjects are re-randomized among second-stage treatments. Sample size calculations for planning these two-stage randomized trials with failure time outcomes are challenging because the variances of common test statistics depend in a complex manner on the joint distribution of time to the early nonresponse criterion or response criterion and the primary failure time outcome. We produce simple, albeit conservative, sample size formulae by using upper bounds on the variances. The resulting formulae only require the working assumptions needed to size a standard single-stage randomized trial and, in common settings, are only mildly conservative. These sample size formulae are based on either a weighted Kaplan-Meier estimator of survival probabilities at a fixed time-point or a weighted version of the log-rank test.

Year:  2011        PMID: 22363091      PMCID: PMC3254237          DOI: 10.1093/biomet/asr019

Source DB:  PubMed          Journal:  Biometrika        ISSN: 0006-3444            Impact factor:   2.445


  16 in total

1.  Estimation of survival distributions of treatment policies in two-stage randomization designs in clinical trials.

Authors:  Jared K Lunceford; Marie Davidian; Anastasios A Tsiatis
Journal:  Biometrics       Date:  2002-03       Impact factor: 2.571

Review 2.  Flexible treatment strategies in chronic disease: clinical and research implications.

Authors:  P W Lavori; R Dawson; A J Rush
Journal:  Biol Psychiatry       Date:  2000-09-15       Impact factor: 13.382

3.  Weighted Kaplan-Meier estimators for two-stage treatment regimes.

Authors:  Sachiko Miyahara; Abdus S Wahed
Journal:  Stat Med       Date:  2010-11-10       Impact factor: 2.373

4.  An experimental design for the development of adaptive treatment strategies.

Authors:  S A Murphy
Journal:  Stat Med       Date:  2005-05-30       Impact factor: 2.373

5.  Dynamic treatment regimes: practical design considerations.

Authors:  Philip W Lavori; Ree Dawson
Journal:  Clin Trials       Date:  2004-02       Impact factor: 2.486

6.  Marginal Mean Models for Dynamic Regimes.

Authors:  S A Murphy; M J van der Laan; J M Robins
Journal:  J Am Stat Assoc       Date:  2001-12-01       Impact factor: 5.033

7.  Developing adaptive treatment strategies in substance abuse research.

Authors:  Susan A Murphy; Kevin G Lynch; David Oslin; James R McKay; Tom TenHave
Journal:  Drug Alcohol Depend       Date:  2006-10-23       Impact factor: 4.492

8.  A randomized, controlled phase III study of cyclophosphamide, doxorubicin, and vincristine with etoposide (CAV-E) or teniposide (CAV-T), followed by recombinant interferon-alpha maintenance therapy or observation, in small cell lung carcinoma patients with complete responses.

Authors:  D Tummarello; D Mari; F Graziano; P Isidori; G Cetto; F Pasini; A Santo; R Cellerino
Journal:  Cancer       Date:  1997-12-15       Impact factor: 6.860

9.  Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design.

Authors:  A John Rush; Maurizio Fava; Stephen R Wisniewski; Philip W Lavori; Madhukar H Trivedi; Harold A Sackeim; Michael E Thase; Andrew A Nierenberg; Frederic M Quitkin; T Michael Kashner; David J Kupfer; Jerrold F Rosenbaum; Jonathan Alpert; Jonathan W Stewart; Patrick J McGrath; Melanie M Biggs; Kathy Shores-Wilson; Barry D Lebowitz; Louise Ritz; George Niederehe
Journal:  Control Clin Trials       Date:  2004-02

10.  Cox regression methods for two-stage randomization designs.

Authors:  Yuliya Lokhnygina; Jeffrey D Helterbrand
Journal:  Biometrics       Date:  2007-04-09       Impact factor: 2.571

View more
  15 in total

1.  Comparing cluster-level dynamic treatment regimens using sequential, multiple assignment, randomized trials: Regression estimation and sample size considerations.

Authors:  Timothy NeCamp; Amy Kilbourne; Daniel Almirall
Journal:  Stat Methods Med Res       Date:  2017-06-19       Impact factor: 3.021

2.  A gate-keeping test for selecting adaptive interventions under general designs of sequential multiple assignment randomized trials.

Authors:  Xiaobo Zhong; Bin Cheng; Min Qian; Ying Kuen Cheung
Journal:  Contemp Clin Trials       Date:  2019-08-27       Impact factor: 2.226

3.  Dynamic Treatment Regimes.

Authors:  Bibhas Chakraborty; Susan A Murphy
Journal:  Annu Rev Stat Appl       Date:  2014       Impact factor: 5.810

4.  LIBERTI: A SMART study in plastic surgery.

Authors:  Jonathan C Hibbard; Jonathan S Friedstat; Sonia M Thomas; Renee E Edkins; C Scott Hultman; Michael R Kosorok
Journal:  Clin Trials       Date:  2018-03-25       Impact factor: 2.486

5.  Sequential, Multiple Assignment, Randomized Trial Designs in Immuno-oncology Research.

Authors:  Kelley M Kidwell; Michael A Postow; Katherine S Panageas
Journal:  Clin Cancer Res       Date:  2017-08-23       Impact factor: 12.531

6.  SMART Design Issues and the Consideration of Opposing Outcomes: Discussion of "Evaluation of Viable Dynamic Treatment Regimes in a Sequentially Randomized Trial of Advanced Prostate Cancer" by by Wang, Rotnitzky, Lin, Millikan, and Thall.

Authors:  Daniel Almirall; Daniel J Lizotte; Susan A Murphy
Journal:  J Am Stat Assoc       Date:  2012-04-27       Impact factor: 5.033

7.  Comparison of adaptive treatment strategies based on longitudinal outcomes in sequential multiple assignment randomized trials.

Authors:  Zhiguo Li
Journal:  Stat Med       Date:  2016-09-19       Impact factor: 2.373

8.  A global logrank test for adaptive treatment strategies based on observational studies.

Authors:  Zhiguo Li; Marcia Valenstein; Paul Pfeiffer; Dara Ganoczy
Journal:  Stat Med       Date:  2013-09-20       Impact factor: 2.373

9.  Estimation of optimal dynamic treatment regimes.

Authors:  Ying-Qi Zhao; Eric B Laber
Journal:  Clin Trials       Date:  2014-05-28       Impact factor: 2.486

10.  Design of sequentially randomized trials for testing adaptive treatment strategies.

Authors:  Semhar B Ogbagaber; Jordan Karp; Abdus S Wahed
Journal:  Stat Med       Date:  2015-09-27       Impact factor: 2.373

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.